Several cases of T-cell leukemia caused by gammaretroviral insertional mutagenesis in children treated for x-linked severe combined immunodeficiency (SCID) by transplantation of autologous gene-modified stem cells were reported. In a comparative analysis, we recently showed that mature T cells, on the contrary, are highly resistant to transformation by gammaretroviral gene transfer. In the present study, we observed immortalization of a single T-cell clone in vitro after gammaretroviral transduction of the T-cell protooncogene LMO2. This clone was CD4/CD8 double-negative, but expressed a single rearranged T-cell receptor. The clone was able to overgrow nonmanipulated competitor T-cell populations in vitro, but no tumor formation was observed after transplantation into Rag-1 deficient recipients. The retroviral integration site (RIS) was found to be near the IL2RA and IL15RA genes. As a consequence, both receptors were constitutively upregulated on the RNA and protein level and the immortalized cell clone was highly IL-2 dependent. Ectopic expression of both, the IL2RA chain and LMO2, induced long-term growth in cultured primary T cells. This study demonstrates that insertional mutagenesis can contribute to immortalization of mature T cells, although this is a rare event. Furthermore, the results show that signaling of the IL-2 receptor and the protooncogene LMO2 can act synergistically in maligniant transformation of mature T lymphocytes.
INTRODUCTION
Myeloid malignancies induced by gammaretroviral vector transfer were reported in several animal models and in a human gene therapy trial (1) (2) (3) . T-cell malignancies were seen in five patients after stem cell gene therapy for severe combined immunodeficiency-X1 (SCID-X1) (4) (5) (6) (7) . Most of the latter clinical cases were induced by vector-mediated insertional transactivation of the protooncogene LMO2. The gene therapy vectors commonly used in the named studies were based on the murine leukemia virus (MLV). Those vectors have the propensity to integrate into active chromatin structures nearby promoter regions (8, 9) . The MLV-based vectors contained full-length long terminal repeats (LTRs) with strong promoter and enhancer activity, not only driving the expression of the delivered transgene, but potentially host genes flanking the integration sites as well (2, 7) .
Currently, it is believed that the target cell most vulnerable to insertional mutagenesis-mediated transformation is a primitive progenitor cell, and that more mature cells are less prone to this adverse event (10, 11) . Furthermore, in clinical trials dealing with gene transfer into mature T cells, malignant transformation has not been observed so far (12) (13) (14) (15) . In a previous study, we addressed this issue by the gammaretroviral transduction of potent (proto)oncogenes into hematopoietic stem cells (HSCs) and mature T lymphocytes. For that experimental setting, we clearly demonstrated that mature T-cell populations are less susceptible to transformation than HSCs (16) .
Nevertheless, several types of T-cell leukemia or lymphoma with a mature phenotype exist, although these are rare diseases. So far, it has not been shown conclusively if those malignancies are really initiated in mature T cells or rather in an immature thymocyte population that retains the ability to differentiate into mature T cells. Mature T cells claim a special position in hematopoiesis, as they show long life spans and a high capacity of self-renewal.
In contrast, differentiated cells generally are limited in their proliferation capacity in vitro and in vivo. The resulting limited life span protects against an accumulation of mutations and a potential transformation.
Here, we describe the in vitro immortalization of a T-cell clone after gammaretroviral gene transfer of the T-cell protooncogene LMO2, due to the insertional transactivation of the genes for the α chains of the Interleukin-2 and Interleukin-15 receptor (IL2RA and IL15RA).
MATERIALS AND METHODS

Retroviral Vectors/Cloning and Reverse Transcription for IL2RA cDNA Generation
MP91-EGFP and MP91-LMO2-EGFP were described previously (16) . The cDNA of the murine IL2RA was generated via reverse transcription (SuperScript II Reverse Transcriptase, Invitrogen, Carlsbad, CA, USA). Total RNA was isolated (RNeasy Mini Kit, Qiagen, Hilden, Germany) from stimulated murine, mature T cells and used for reverse transcription with an IL2RA specific primer (IL2Ra-RT-Rev: CGTCT CAGAT TTGGCTTGAG). Generated IL2RA-cDNA was furthermore amplified (with following primers: IL2Ra-Forw: GTGCCAGGAA GATGGAG; IL2Ra-Rev: CATCCGCTTGCC TGGGCTC) and the PCR product then was cloned into MP91-EGFP in front of an internal ribosome entry site (IRES). The cDNA of the murine IL15RA was obtained from RZPD Deutsches Ressourcenzentrum für Genomforschung (ImaGenes, Berlin, Germany) and also cloned into MP91-EGFP as described for IL2RA. To enable the detection of triple transduced cells (IL2RA, IL15RA, LMO2), we substituted EGFP with the fluorescent marker Venus (17) in the IL2RA encoding vector and with the fluorescent marker Cerulean (18) in the IL15RA encoding vector, respectively.
Retroviral Particle Production
Vector supernatants were produced in Dulbecco's modified Eagle medium (Lonza, Rockville, MD, USA) supplemented with 10% fetal calf serum (Pan Biotech, Aidenbach, Germany), 2% L-glutamine (Lonza), and 1% Pen/Strep (PAA Laboratories, Coelbe, Germany). Ecotropic supernatant was produced in a split genome approach by calciumphosphate-mediated transient transfection of 293T human embryonic kidney producer cells. After 24, 48 and 60 h, supernatant was collected, filtered (0.45 μm), and stored at 4°C for a maximum of 1 wk. All supernatants were pooled and titrated on the embryonic murine fibroblast SC-1 cell line. After titration, supernatant was used directly for transduction.
Retroviral Transduction and Culture Conditions
Murine mononuclear cells were isolated from the spleen and the lymph nodes (mesenteric and superficial inguinal) of C57BL/6J.Ly5.2 mice (Charles River Laboratories, Sulzfeld, Germany) and stimulated by anti-CD3 (clone 145-2C11), anti-CD28 monoclonal antibody (mAb, clone 37.51; both from BD Biosciences PharMingen) coated paramagnetic beads (Invitrogen) for 4 d to obtain stimulated mature T cells. The use of paramagnetic beads conjugated with mAb has been described previously (19) . At d 4 after isolation, cells were transduced on vector supernatant-preloaded culture plates (BD), precoated with 50 μg/mL retronectin (Takara, Kyoto, Japan). Stimulated mature T cells were kept in RPMI 1640 (Lonza), supplemented with 10% fetal calf serum (Pan Biotech), 2% L-glutamine (Lonza), 1% Pen/Strep (PAA Laboratories), 1% sodium pyruvate (Invitrogen), 1% nonessential amino acids (Invitrogen) and 0.1% β-mercaptoethanol (Invitrogen) throughout the entire cultivation time. Culture conditions also included human IL-2 (Roche Diagnostics, Mannheim, Germany) at 100 U/mL for stimulation.
LM-PCR
Ligation-mediated polymerase chain reaction (LM-PCR) was performed as previously described (20) . Genomic DNA was prepared, using the DNeasy Blood & Tissue Kit (Qiagen). After LM-PCR and subsequent sequencing, the identified integrations, which contained at least the LTR or polylinker sequence, were BLAST aligned using the NCBI36 mouse genome build (accessed October 2010).
Genes within 200kb upstream and downstream of the vector integrations as well as the genes closest to the integration sites were identified using NCBI map view data (accessed October 2010).
Integration-Site Specific PCR
To analyze clonality after limited dilution, integration-site specific PCR (and subsequent Nested-PCR) of 14 established clones was performed. Vector specific primers: Vector 1: 5′-CCATG CCTTG CAAAATGGC, Vector_Nested: 5′-CTTGC AAAATGGCGTTAC. Integration specific primers for Hod1 on chromosome 5: Hod1_1: 5′-GGCTGTTGGA TATTATGGAT GC, Hod1_Nested: 5′-CATGCTGACC TTTGGAGTGA; for IL2RA/IL15RA on chromosome 2: IL2RA/IL15RA_1: 5′-CCTGACTACCAGAATAGTGCAAAA, IL2RA/IL15RA_Nested: 5′-GAGCCCC CATATCTCTCTCC.
Microarray Analysis
Miltenyi Biotech performed Microarray ratio experiments commercially. RNA was isolated from fresh murine T lymphocytes, thymocytes and the immortalized T-cell population (each 1 × 10 7 cells from 8-wk-old C57BL/6 wild type (WT) donor animals) using standard RNA extraction protocols (NucleoSpin RNA II, Macherey-Nagel, Düren, Germany 
Flow Cytometric Analyses
Flow cytometric analyses were carried out on freshly isolated and long-term cultured murine T cells. The following anti-mouse monoclonal antibodies were used for staining: rat anti-mouse monoclonal antibodies (Invitrogen): phycoerythrin (PE)-conjugated CD8a (CT-CD8a), CD44 (IM7.8. . Analyses were performed on a FACScalibur using the CellquestPro software (both from BD Biosciences PharMingen). All cell counts were performed on a CASYCell Counter (Schärfe System, Reutlingen, Germany). Detection of T cells transduced with multiple colors (EGFP, Venus and Cerulean) was performed on a BD FACS Canto II and analyzed using BD FACSDiva 6.0 software.
PCR Analysis of the Expressed Vβ-TCR Repertoire
Analysis of the diversity in the T-cell antigen receptor (TCR) repertoire of polyclonal WT (C57BL6J.Ly5.2) T cells and the immortalized T-cell population was essentially performed as described (21) . Shortly, after isolating total RNA (RNeasy Mini Kit, Qiagen) from 5 × 10 
Western Blotting
For Western blot expression studies of IL15RA we prepared cell lysates from freshly isolated mature T cells, 4 d anti-CD3/CD28 stimulated T cells (from 8-wk-old WT C57BL/6 donors) and the immortalized T-cell clone (each 5 × 10 6 cells). As a primary antibody we used rat anti-IL15RA (AZ-12) in a 1:200 dilution (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Western blotting was performed according to the manufacturer's instructions; the primary antibody was detected with horseradish peroxidase-conjugated secondary antibody: goat anti-rat HRP in a 1:10000 dilution (Santa Cruz Biotechnology).
Annexin-V staining
Apoptosis induction of the immortalized T-cell population was verified by staining with the Annexin V-PE Apoptosis Detection Kit I (BD Biosciences) following the manufacturer's instructions. Immortalized cells were cultured in the presence of different interleukin-2 concentrations (400 U/mL, 100 U/mL, 50 U/mL, 0 U/mL) for 48 h and used in the apoptosis assay. Analysis was performed on a FACScalibur (BD Biosciences).
All supplementary materials are available online at www.molmed.org.
RESULTS
Immortalization of Primary Murine T Cells after Retroviral Transduction with the T-Cell Protooncogene LMO2
To investigate the susceptibility of mature T cells to transformation in vitro, we utilized gammaretroviral gene transfer of the potent T-cell protooncogene LMO2. The gammaretroviral vector MP91-LMO2 coexpresses EGFP as a marker gene via an IRES element. A vector encoding EGFP only (MP91-EGFP) served as a control ( Figure 1A) .
T cells were isolated from lymph nodes and spleens of adult C57BL/6J.Ly5.2 mice and transduced following 4 d of anti-CD3/28 prestimulation. High multiplicities of infection (MOI) between 50 and 300 were used to achieve high transduction efficacies with multiple integrations. Per vector, we initiated 53 independent cultures (a total of 106) with cell counts in the range of 3 × 10 4 to 1 × 10 6 , each. Fifty to 60% of the cells were gene modified in the cultures as determined by EGFP expression and the majority of the cells were of a CD8+ T-cell phenotype. One culture per vector is shown representatively in Figure 1B . The cells then were passaged for at least 12 wks, with supplementation of 100 U/mL interleukin-2 (IL-2) to assess the potential outgrowth of immortalized cell clones.
In a pilot experiment, clonal dynamics were analyzed by LM-PCR of 7 MP91-EGFP-transduced T-cell cultures 4, 11 and 84 d after transduction. As early as 11 d after transduction, certain clones began to dominate (one culture is shown representatively in Supplementary Figure 1) . However, these T-cell cultures did not survive beyond wk 12 and no obviously growth-promoting genes flanked the retroviral integration sites, even in a 400 kb window of analysis (data not shown).
Only one LMO2-transduced T-cell culture of the 106 cultures initiated (frequency < 1%) had the ability to grow continuously for more than 12 wks. This culture was passaged for nearly 1 year, was > 98% EGFP positive with a CD4/CD8 double-negative phenotype (Figure 2A ). Other mature T-cell markers, such as the T-cell receptor α/β chains and CD3, were expressed ( Figure 2B ). Particularly, high expression levels were seen for the T-cell-specific activation markers CD25 and Sca1. The low expression of the heat stable antigen (CD24) also was supportive of a mature T-cell phenotype. The leukocyte antigen CD11a was expressed on all cells. Markers for the following lineages were negative: B cells (CD19), natural killer cells (NK1.1), other T-cell types (TCRγ/δ), stem cells (CD90, CD117), some T-cell markers (CD2, CD5) and immature T-cell antigens (pre-α-TCR). As expected, CD27 was downregulated after prolonged activation in vitro (22) . Taking the expression of CD44 and the lack of the homing marker L-selectin (CD62L) as well as the high CD25 expression into consideration, this profile resembles a memory T-cell phenotype, despite the absence of CD4 and CD8.
Immortalized T cells were cocultured on OP9-DL1 cells, which are known to support in vitro T-cell differentiation (23) , with the aim to regain CD4 or CD8 coreceptor expression (data not shown). But, even after repeated attempts, the cells remained CD4 and CD8
-. This observation supports the conclusion that the immortalized cells most closely resemble memory T cells and not double-negative thymocytes.
Growth Characteristics and Clonality of the in vitro Immortalized T-Cell Population
The immortalized T-cell population remained IL-2 dependent. Decreasing amounts of IL-2 in the culture resulted in massive apoptosis, which was detected by Annexin V staining ( Figure 3A) . To further address the growth properties of the immortalized cells, a competition experiment with nonmanipulated, primary T lymphocytes was initiated. Nontransduced primary T cells were stimulated for 4 d in vitro and mixed with the immortalized cells. In four independent experiments, the initial culture (d 0) was established with 10% cells from the immortalized T-cell culture and 90% freshly stimulated, nonmanipulated T cells. Cells were cultured in the presence of 100 U/mL IL-2 and on d 2, 6 and 8 EGFP expression was determined as an indicator for the proportion of immortalized cells and their competitiveness. The immortalized T-cell population clearly overgrew the competitor cells rapidly and dominated the culture on d 8 ( Figure 3B ).
We next assessed whether the immortalized T cells were capable of inducing T-cell leukemia/lymphoma in an immunodeficient mouse model. However, the immortalized T cells were not capable of giving rise to leukemia/lymphoma after transplantation into Rag-1 deficient syngeneic mice.
The clonality of the immortalized population was analyzed by PCR for the expressed T-cell receptor (TCR) Vβ-chain. To analyze the Vβ-chain expression via FACS, we used freshly isolated WT T cells as a positive control (data not shown). Compared to WT T cells, we could only detect a signal for the variable β-chain 13 (Vβ13) in the immortalized population ( Figures 4A, B) , which was indicative of a monoclonal T-cell population. Furthermore, only a limited number of integrations were detected by LM-PCR ( Figure 5A ). Among the integrations mapped for this immortalized T-cell population, one turned out to be very interesting. The integration was mapped closely to the gene cluster of the IL-2 receptor α (IL2RA) and IL-15 receptor α (IL15RA) genes ( Figure 5B ). The vector insertion was in reverse orientation in sufficiently close proximity to potentially transactivate these genes (23kb to IL2RA and 86kb to IL15RA, respectively). Especially, a subsequent overexpression of IL2RA appears to be a critical event, as it is enlisted in the retroviral tagged cancer gene database (RTCGD), see Table 1 . A detailed list of all mapped genes flanking the retroviral integration sites in a 400 kb window, in the immortalized T-cell population is enclosed in Table 1 .
The cells were cloned by limited dilution and integration-site-specific PCR was performed on 14 established clones. In all analyzed clones, we could reproducibly detect the investigated integrations on chromosome 2 (near IL2RA/IL15RA) and chromosome 5 (near Hod1) (Supplementary Figure S2 ). Moreover, we solely identified Vβ13-rearrangement in the obtained subclones (data not shown). Subsequently, based on these results, we declared the population as clonal. Further analyses were performed on clone 8.
Overexpression of IL2RA and IL15RA Promoted Immortalization
In a microarray ratio experiment, we compared the expression profile of the immortalized T-cell clone to that of mature and immature T lymphocytes. But, the pattern of up-or downregulated genes of the immortalized T-cell clone differed significantly from both cell types ( Figure 6 ). The overexpression of the IL2RA (CD25) detected via FACS analysis (see Figure 2B ) was verified by the microarray expression data. The immortalized T cells expressed 50-and/or 100-fold higher levels of the IL2RA mRNA, respectively, than the nonstimulated, mature T cells and/or the thymo- Figure 3) .
To directly assess the role of IL2RA and IL15RA, we finally expressed the two receptor chains ectopically. For this purpose, we cloned the murine cDNAs of the two chains each into the MP91-EGFP vector resulting in the vectors MP91-IL2RA and MP91-IL15RA. We replaced EGFP by fluorescent marker Venus in the IL2RA-encoding vector and by Cerulean in the IL15RA-encoding vector ( Figure 7A ). We transduced primary murine T cells with either LMO2, IL2RA or IL15RA alone or with all possible vector combinations: LMO2 + IL2RA, LMO2 + IL15RA, IL2RA + IL15RA and LMO2 + IL2RA + IL15RA. As control populations, we initiated control vector MP91-EGFP-transduced and nonmodified T lymphocyte cultures.
To address the influence of the investigated transgenes exclusively, we minimized gammaretroviral insertional site effects by working with low copy numbers of the transferred vectors (0.2%-6% transduction efficacy). To ectopically mimic the previously observed insertional transactivation, we started with an absolute number of 4,700 tripletransduced (LMO2 + IL2RA + IL15RA) T lymphocytes.
The cells were passaged under standard culture conditions. Over time the levels of gene marking increased from 6% to 100% in IL2RA cultures and from 3% to 100% in LMO2 + IL2RA cultures, respectively ( Figure 7B ). Nevertheless, only T cells transduced with IL2RA in combination with LMO2 demonstrated sustained growth after a critical in vitro cultivation time of 8 wks ( Figure 7C ). However, a full immortalization was not achieved, as we were not able to cultivate these cells as long as the immortalized T-cell clone (not longer than 12 wks). Even triple overexpression of LMO2, IL2RA and IL15RA in mature T lymphocytes did not induce any growth/proliferation-enhancing effect. This observation indicates that further survival-promoting events besides insertional mutagenesis may have contributed to immortalization of the original clone. Alternatively, one might suggest that the levels of ectopic expression achieved by retroviral gene transfer differ significantly from those resulting from the transactivation event.
DISCUSSION
In the present study, we initiated a total of 106 primary murine T-cell cultures, half of them following retroviral transduction of the LMO2 T-cell protooncogene. In one culture (approximately 1%), we observed a fully immortalized T-cell clone with unlimited growth potential. The immortalized cell clone was CD4 and CD8 double negative but expressed a rearranged, monoclonal T-cell receptor β-chain. The immortalized cells were not able to initiate leukemia/lymphoma after transplantation into syngeneic Rag-1 deficient recipient mice. According to integration analysis and expression profiles, we found the immortalization to be caused by insertional transactivation of IL2RA and IL15RA in combination with the ectopic expression of LMO2. Here we report about the rare event of insertional mutagenesis-mediated T-cell immortalization.
The immortalized clone did not express the T-cell markers CD4 and/or CD8. Loss of T-cell identity due to oncogene expression is a phenomenon which also is sporadically observed in mature T-cell leukemia/lymphoma (24) . Furthermore, dedifferentiation of malignant lymphocytes recently was described for mature B lymphocytes during the development of Hodgkin's lymphoma (25) .
Moreover, induced pluripotent stem cells (IPSCs) are generated by overexpression of self-renewal promoting genes in fully differentiated cell types (26, 27) . Thus, dedifferentiation and immortalization are often associated. Interestingly, the IL2RA is highly expressed in immature, developing lymphocytes. Therefore, the overexpression of the IL2RA in our clone is in line with a dedifferentiated T-cell phenotype and could even have contributed to the loss of mature T-cell markers.
Clearly, after ectopic expression, we observed a growth-enhancing effect in IL2RA and LMO2 double-transduced T cells. This result is consistent with speculations that signaling of the IL-2 receptor and the protooncogene LMO2 can act synergistically in malignization of T lymphocytes, as assumed for the adverse site effects observed in patients of the SCID-X1 gene therapy trial (28) .
However, we were not able to induce an identically immortalized phenotype by the ectopic expression of IL2RA alone or in combination with LMO2 and IL15RA. Therefore, we assume that overexpression of these genes is not sufficient to immortalize T lymphocytes. It might well be speculated that, in addition to overexpression of LMO2 and IL2RA/IL15RA, further mutations acquired in the immortalized T-cell clone were involved in the full manifestation of the observed phenomenon.
The low immortalization rate found in this study confirms our previous finding that mature T cells are highly resistant to gammaretroviral insertional mutagenesis. This is unexpected as T lymphocytes present unique characteristics associated with susceptibility to malignant transformation (16, 29) . They have an impressive replicative capacity allowing them to respond to antigen challenges with dramatic proliferation bursts and they are capable of long-term self-renewal.
It is commonly accepted that complete malignant transformation requires multiple genetic lesions which deregulate cell differentiation and apoptosis and stimulate proliferation (30, 31) . LMO2 overexpression alone, for instance, is not sufficient for the development of leukemia (32). However, MLV-based vectors, such as the ones used in this study, are highly genotoxic and could add additional genetic lesions that allow full immortalization or transformation. As they integrate preferentially near accessible, open and transcribed promoters, and since T cells need some level of activation and must be cycling to be transduced with a gammaretroviral vector, integration near proliferation-supporting or antiapoptotic genes is obviously favored by MLV-based vectors (14) . Transactivation of such genes could indeed act as cooperating transforming events in gammaretroviral gene transfer into mature T lymphocytes. Recently, it was reported that derepression of an endogenous LTR can activate a protooncogene in human lymphoma (33) .
In accord with this prediction, the immortalized T-cell clone described in this study showed an insertional activation of the IL2RA and IL15RA genes. Both genes play a crucial role in T-cell proliferation and survival. IL2RA expression occurs in early T and B lymphocytes and is induced during activation of mature lymphocytes, including regulatory T cells. It acts as a cell cycle progression factor and promotes functional differentiation of T and B cells (34) . In homeostasis, IL-2 levels and IL2RA expression control the balance between clonal expansion and cell death following immune activation (35) . The immortalized T-cell clone still showed a dramatic IL-2-dependency (see Figure 3A) . However, even in the presence of high IL-2 concentrations, a high percentage of apoptotic cells were always present in the culture. An explanation for this observation could be that IL2RA signaling not only provides a proliferation signal, but, depending on additional signals, also can drive T cells into apoptosis. However, the immortalized T-cell population was capable of exploiting the IL-2 resources very efficiently and thereby out competed freshly stimulated, cocultured T cells (see Figure 3B) .
Along with the IL2RA upregulation, we observed a transactivation of the IL15RA gene. The α-chain of the IL-15 receptor shares the β-and γ-chains with the IL-2 receptor and plays a crucial role in T-cell homeostasis, expansion and survival (36) . IL-15 transgenic animals develop fatal lymphocytic leukemia of a T-NK phenotype (37) . The overexpression of the IL-15 receptor or a constitutive activation of the IL-15R signaling pathway can present important growth and survival factors in the leukemogenesis of T cells.
Interestingly, in a previous study (16), we observed a very similar retroviral integration site (Table S6A , clone GFPA8_161-PCR). The insertion site was located in even closer proximity to the IL2RA-and IL15RA-gene locus (distance of 1.8 kb). It was detected in EGFP-transduced, mature T cells, after long-term persistence of the cells in vivo (481 d after transplantation). Even after a long latency, the isolated T cells carrying this integration site were polyclonal and showed no signs of malignancy. This observation further supports our finding that at least ectopic coexpression of LMO2 was required for full immortalization. Furthermore, additional mechanisms may control the immortalization and/or D 1 7 ( 1 1 -1 2 ) 1 2 2 3 -1 2 3 2 , N transformation of mature T cells in vivo which are not active in vitro (for example, clonal competition).
The conclusion that the specific retroviral integration indeed contributed to the immortalization of the T-cell clone in this study is supported by the known growth-promoting activity of IL2RA and IL15RA, the fact that both genes were indeed persistently upregulated and the observation that the ectopic expression of LMO2 in combination with IL2RA supported long-term growth of T cells in vitro. Others have reported previously such an immortalization of T lymphocytes. Retroviral gene transfer of IL-15 was found to induce a cytokine-independent growth of primary human cytotoxic T cells (38) and the overexpression of the antiapoptotic gene Bcl-2 enhanced the persistence of tumor-specific T cells in vivo (39) . This report, however, shows that retroviral insertional mutagenesis can contribute to the immortalization of mature T cells. On the other hand, we found this to be an extremely rare event, full transformation with in vivo leukemogenicity was not observed and additional ectopic expression of a T-cell protooncogene was required for full immortalization. Moreover, this result could not be reproduced with human T cells, although we performed even more extensive and repeated (a total of several hundred cultures with a total of around 10 9 T cells) experiments with human peripheral blood mononuclear cells (PBMCs). Therefore, this study clearly shows that gammaretroviral insertional mutagenesis can alter the phenotype of mature T lymphocytes, however, the chance of transformation is extremely low. This reflects the absence of any genotoxic events in past clinical trials involving the genetic modification of mature T lymphocytes. Although, we can conclude that therapeutic retroviral gene transfer into mature T lymphocytes is not associated with a significant risk of insertional mutagenesis, our study clearly demonstrates, that under certain conditions, insertional genotoxicity can lead to survival-enhancing effects or even immortalization in mature T cells. Therefore, the presented in vitro system might be considered as a test procedure for therapeutic transgenes of T-cell based clinical gene therapy trials.
